
CDMO
CDMO contract development and manufacturing: a Global Top-tier partnership and cGMP verified infrastructure
From Preclinical Development to Commercialization,
We Provide End-to-End CDMO Services.
Flexible solutions tailored to each stage of development, supporting your projects from early development through commercialization.
Global Top-tier
CDMO Partnership
Partnership with a global top-tier CDMO
Based on global infrastructure including Porton,
we deliver the optimal CDMO solution.
Our Strengths & Capabilities
Exclusive Partnership with Porton
Exclusive partnership with Porton, a global top-tier CDMO
We manage projects locally in Korea and provide access to Porton's proven global manufacturing infrastructure for reliable development and production.Global GMP Infrastructure
cGMP manufacturing infrastructure aligned with FDA, EMA, and PMDA standards
Our global-standard manufacturing infrastructure supports projects targeting international markets and regulatory approvals.From KSM development to Drug Product (DP) manufacturing
We provide end-to-end services covering KSM (Key Starting Material) development under Non-GMP and GMP conditions, customized process development, contract synthesis, and FDF manufacturing.
Support at Every Development Stage
Flexible support from preclinical development to commercialization
From early-stage material supply and small-scale synthesis to clinical-scale production and continued commercial supply, we provide solutions tailored to each stage of development.
Procedure of CDMO
Raw Material to DP
We provide end-to-end CDMO services, from KSM development to finished dosage form (FDF) manufacturing.
KSM Development & Supply
- We develop and supply Key Starting Materials (KSMs) in accordance with Non-GMP and GMP requirements.
Customized Process Development
- We develop processes tailored to target formulations and quality requirements, with flexible support based on the development stage and project needs.
Contract Synthesis & Manufacturing
- We support contract synthesis of a wide range of compounds, including complex molecules, through proven manufacturing infrastructure.
- Access to Porton's cGMP manufacturing infrastructure aligned with FDA, EMA, and PMDA standards
DP Manufacturing
- We provide integrated CDMO services extending from raw material and intermediate development through Drug Product (DP) manufacturing.

- Dedicated CDMO
inquiry intake - KSM development(Key starting material)
- Custom process development
- Contract synthesis
- Finished dosage form (FDF)
contract manufacturing
Scope of support by development stage
Preclinical
- Securing early materials
- Small-scale synthesis
Solution
- KSM (Key starting material) developmentStarting material developed and supplied at Non-GMP · GMP level
- Custom process developmentProcess designed for the target dosage form and specification
Phase 1 · 2 · 3
- Stabilizing the process while scaling up
- Process validation for commercial production
Solution
- Contract synthesisEven demanding compounds synthesized on verified facilities
- cGMP verified infrastructureInfrastructure that has passed FDA · EMA · PMDA verification
Commercialization
- A continuous supply system aligned with approved specifications
Solution
- Finished dosage form (FDF) contract manufacturingConnected in one flow through finished production
- Support for overseas expansionContract manufacturing for Korean pharmaceutical and bio companies expanding abroad
CDMO projects,
from early design through approval to mass production,
solved in one stop.
Tell us the development goal you have in mind,
and our team will reply promptly

